To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.
About This Bill
Committee
Latest Action · December 22, 2023
Referred to the House Committee on Armed Services.